Polaryx Therapeutics, Inc. Accounts Payable increased by 80.9% to $850.00K in Q1 2026 compared to the prior quarter.
An increase can indicate better credit terms or increased production volume, while a decrease might suggest faster payments or reduced purchasing.
The amount of money a company owes to its suppliers and vendors for goods and services purchased on credit. In a large-s...
Companies with significant supply chain leverage often maintain high payables to maximize their own cash-on-hand.
accounts_payable| Q1 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|
| Value | -$17.00K | $470.00K | $850.00K |
| QoQ Change | — | >999% | +80.9% |
| YoY Change | — | — | >999% |